Survival of antigen-experienced T cells is essential for the generation of adaptive immune responses. Here, we show that the genetic and antibody-mediated inactivation of CD152 (cytotoxic T lymphocyte antigen 4) in T helper (Th) effector cells reduced the frequency of nonapoptotic cells in a completely Fas/Fas ligand (FasL)–dependent manner. CD152 cross-linking together with stimulation of CD3 and CD28 on activated Th2 cells prevented activation-induced cell death (AICD) as a result of reduced Fas and FasL expression. Apoptosis protection conferred by CD152 correlated with the up-regulation of Bcl-2 and was mediated by phosphatidylinositol 3 kinase, which prevented FasL expression through the inhibitory phosphorylation of Forkhead transcription factor FKHRL1. We show that signals induced by CD152 act directly on activated T lymphocytes and, due to its differential surface expression on activated Th1 and Th2 cells, induce resistance to AICD mainly in Th2 cells.
Article navigation
15 March 2004
Article|
March 08 2004
CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase Function
Pushpa Pandiyan,
Pushpa Pandiyan
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Dagmar Gärtner,
Dagmar Gärtner
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Osman Soezeri,
Osman Soezeri
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Andreas Radbruch,
Andreas Radbruch
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Klaus Schulze-Osthoff,
Klaus Schulze-Osthoff
2Institut für Molekulare Medizin, Universität Düsseldorf,
Search for other works by this author on:
Monika C. Brunner-Weinzierl
Monika C. Brunner-Weinzierl
1Deutsches Rheuma-Forschungszentrum Berlin
3Medizinische Kliniken der Humboldt-Universität zu Berlin, Charité, 10117 Berlin, Germany
Search for other works by this author on:
Pushpa Pandiyan
1Deutsches Rheuma-Forschungszentrum Berlin
Dagmar Gärtner
1Deutsches Rheuma-Forschungszentrum Berlin
Osman Soezeri
1Deutsches Rheuma-Forschungszentrum Berlin
Andreas Radbruch
1Deutsches Rheuma-Forschungszentrum Berlin
Klaus Schulze-Osthoff
2Institut für Molekulare Medizin, Universität Düsseldorf,
Monika C. Brunner-Weinzierl
1Deutsches Rheuma-Forschungszentrum Berlin
3Medizinische Kliniken der Humboldt-Universität zu Berlin, Charité, 10117 Berlin, Germany
Address correspondence to Monika C. Brunner-Weinzierl, Deutsches Rheuma-Forschungszentrum, Schumannstrasse 21/22, 10117 Berlin, Germany. Phone: 49-30-28460-721; Fax: 49-30-28460-603; email: [email protected]
Abbreviations used in this paper: AICD, activation-induced cell death; CFSE, 5,6-carboxyfluorescein diacetate succinimidyl ester; dB-cAMP, dibutyryl cAMP; FasL, Fas ligand; tg, transgenic; PI, propidium iodide; PI3 K, phosphatidylinositol 3 kinase; TUNEL, TdT-mediated dUTP nick-end labeling.
Received:
June 27 2003
Accepted:
January 23 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (6): 831–842.
Article history
Received:
June 27 2003
Accepted:
January 23 2004
Citation
Pushpa Pandiyan, Dagmar Gärtner, Osman Soezeri, Andreas Radbruch, Klaus Schulze-Osthoff, Monika C. Brunner-Weinzierl; CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase Function . J Exp Med 15 March 2004; 199 (6): 831–842. doi: https://doi.org/10.1084/jem.20031058
Download citation file:
Sign in
Don't already have an account? Register
Suggested Content
Email alerts
Advertisement
